E2 affected pathways in eSFstage-I involved endometrial function/dysfunction and endometriosis (e.g. MAPK, PI3K-Akt, ErbB signaling, focal adhesion, gap junctions, among others (Table 1)). The gene discussed is EGFR; the disease is endometriosis.